Literature DB >> 23002375

Clopidogrel compared with other antiplatelet agents for secondary prevention of vascular events in adults undergoing percutaneous coronary intervention: clinical and cost-effectiveness analyses.

Sy Chen, E Russell, S Banerjee, B Hutton, A Brown, K Asakawa, L McGahan, M Clark, M Severn, J Cox, M Sharma.   

Abstract

Entities:  

Year:  2012        PMID： 23002375      PMCID： PMC3442611     

Source DB:  PubMed          Journal:  CADTH Technol Overv        ISSN： 1203-9012


× No keyword cloud information.
  29 in total

Review 1.  Publication and related biases.

Authors:  F Song; A J Eastwood; S Gilbody; L Duley; A J Sutton
Journal:  Health Technol Assess       Date:  2000       Impact factor: 4.014

2.  Prevention of acute complications after percutaneous transluminal coronary angioplasty.

Authors:  M G Bourassa; L Schwartz; J Lespérance; C Eastwood; F Kazim
Journal:  Thromb Res Suppl       Date:  1990

3.  A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.

Authors:  Guido Parodi; Roberto Sciagrà; Angela Migliorini; Gentian Memisha; Guia Moschi; Renato Valenti; Alberto Pupi; David Antoniucci
Journal:  Am Heart J       Date:  2005-08       Impact factor: 4.749

4.  A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation.

Authors:  P Hall; S Nakamura; L Maiello; A Itoh; S Blengino; G Martini; M Ferraro; A Colombo
Journal:  Circulation       Date:  1996-01-15       Impact factor: 29.690

5.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Authors:  Steven R Steinhubl; Peter B Berger; J Tift Mann; Edward T A Fry; Augustin DeLago; Charles Wilmer; Eric J Topol
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

6.  Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.

Authors:  S R Mehta; S Yusuf; R J Peters; M E Bertrand; B S Lewis; M K Natarajan; K Malmberg; H Rupprecht; F Zhao; S Chrolavicius; I Copland; K A Fox
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

7.  A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents.

Authors:  C Müller; H J Büttner; J Petersen; H Roskamm
Journal:  Circulation       Date:  2000-02-15       Impact factor: 29.690

8.  Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Robert A Harrington; Richard C Becker; Christopher P Cannon; David Gutterman; A Michael Lincoff; Jeffrey J Popma; Gabriel Steg; Gordon H Guyatt; Shaun G Goodman
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

9.  Cost-effectiveness of clopidogrel treatment in percutaneous coronary intervention: a European model based on a meta-analysis of the PCI-CURE, CREDO and PCI-CLARITY trials.

Authors:  Jenny Berg; Dogan Fidan; Peter Lindgren
Journal:  Curr Med Res Opin       Date:  2008-06-10       Impact factor: 2.580

Review 10.  Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.

Authors:  Lisa T Newsome; Michael A Kutcher; Roger L Royster
Journal:  Anesth Analg       Date:  2008-08       Impact factor: 5.108
View more
  1 in total

1.  Evaluate Short-Term Outcomes of abciximab in ST-Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Clinical Trials.

Authors:  Nan Bai; Ying Niu; Ying Ma; Yao-Sheng Shang; Peng-Yu Zhong; Zhi-Lu Wang
Journal:  J Interv Cardiol       Date:  2022-05-29       Impact factor: 1.776
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.